GGrantIndex
Sort

64,565 grants matching drug discovery

UCSD Cancer Center Training Program in Drug Development

$517,140
Stephen B Howell · University Of California, San Diego · T32 · FY2015 · CA

Theory and Modeling of Noncovalent Binding

$517,102
Michael K. Gilson · University Of California, San Diego · R01 · FY2020 · GM

Molecular screen for isopeptidase inhibitors to treat pulmonary disease

$517,089
David E Sterner · Progenra, Inc. · R44 · FY2010 · HL

Mechanism and Inhibition of HIV Reverse Transcriptase

$517,078
Karen S Anderson · Yale University · R01 · FY2012 · GM

Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine Signaling

$517,047
Bertha K Madras · Mclean Hospital · R01 · FY2017 · DA

Viral and Host Proteins as Therapeutic Targets

$517,006
Stuart F. J. Le Grice · Basic Sciences · Z01 · FY2007 · CA

HIV-1 RNase H as a Therapeutic Target

$517,005
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

PHYSIOLOGY AND GENETICS OF GDNF FAMILY OF LIGANDS

$516,992
Jeffrey D Milbrandt · Washington University · R01 · FY2014 · AG

PHYSIOLOGY AND GENETICS OF GDNF FAMILY OF LIGANDS

$516,992
Jeffrey D Milbrandt · Washington University · R01 · FY2012 · AG

PHYSIOLOGY AND GENETICS OF GDNF FAMILY OF LIGANDS

$516,990
Jeffrey D Milbrandt · Washington University · R01 · FY2011 · AG

Structure-based Design of Selective Serotonin Biased Agonists as Chemical Probes for Psychedelic Potential

$516,972
John D McCorvy · Medical College Of Wisconsin · R01 · FY2024 · MH

Structure-based Design of Selective Serotonin Biased Agonists as Chemical Probes for Psychedelic Potential

$516,972
John D McCorvy · Medical College Of Wisconsin · R01 · FY2025 · MH

Legacy continuation of the KU CMLD Mission

$516,951
Thomas Edward Prisinzano · University Of Kansas Lawrence · R24 · FY2015 · GM

A Novel Pharmacotherapy for Glaucoma

$516,925
Ganesh A Thakur · Northeastern University · R01 · FY2014 · EY

Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer

$516,900
Shiaowen David Hsu · Duke University · U01 · FY2021 · CA

Identifying patterns of human polysubstance use to guidedevelopment of rodent models

$516,884
Lori A Knackstedt · University Of Florida · R33 · FY2020 · DA

CNV And Stroke (CaNVAS)

$516,872
John W. Cole · University Of Maryland Baltimore · R01 · FY2021 · NS

Target Selection and Ligand Discovery

$516,831
Frederick Simmons Buckner · University Of Washington · P01 · FY2007 · AI

miRNA HD Array Platform

$516,831
Bruce E. Seligmann · Htg Molecular Diagnostics, Inc. · R43 · FY2009 · AI

Unifying Templates, Ontologies and Tools to Achieve Effective Annotation of Bioassay Protocols

$516,810
Stephan C Schurer · University Of Miami School Of Medicine · U01 · FY2018 · LM

Preventing lethal hemorrhagic fever caused by hantaviruses by preserving endothel

$516,744
Alan L Mueller · Navigen, Inc. · R01 · FY2011 · AI

Vitamin C (ascorbic acid) recommended dietary ingestion

$516,740
Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di

$516,709
Sankar Adhya · Basic Sciences · Z01 · FY2007 · CA

Discovery and Development of Compounds to Enhance b-cell Number and Function

$516,697
Cathy A Swindlehurst · Novomedix, Inc. · R43 · FY2007 · DK

Sugar signaling networks detected by high content fluxomics

$516,685
Wolf B Frommer · Carnegie Institution Of Washington, D.C. · R01 · FY2007 · DK